HVR Cardio closes on $11 million series b financing with Finland’s innovestor life science fund and Tesi 11.1.2023
Suomalainen sydänkirurgian laitekehittäjä HVR Cardio on varmistanut yli 10 miljoonan euron rahoituskierroksen. Yhtiön teknologia on saanut USA:n viranomaisten läpimurtoluokituksen. 11.1.2023
HVR Cardio CEO to Present at the Nordic-American Life Science Investment and Partnering Conference 11.11.2020
FDA grants Breakthrough Device designation to CathHELIX®, HVR Cardio’s catheter-based mitral valve repair device 25.9.2019
Clinical Study Results Reveal Improved Heart Condition with HVR Cardio Annuloplasty Ring (MAR) 17.10.2016
Data Collection Completed for the Clinical Study Evaluating HVR Cardio Annuloplasty Ring Safety and Performance 22.8.2016
HVR Cardio Helix Ring for Mitral Valve Repair Continues to Achieve All Objectives in Approval Study 31.7.2013
